Stay updated on Avelumab in Chemo-resistant GTN Clinical Trial
Sign up to get notified when there's something new on the Avelumab in Chemo-resistant GTN Clinical Trial page.

Latest updates to the Avelumab in Chemo-resistant GTN Clinical Trial page
- Check3 days agoChange DetectedThe page revision label changed from v3.5.4 to v3.5.5. This appears to be a minor maintenance update and does not alter the study content or results.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedThe site revision label was updated from v3.5.3 to v3.5.4, indicating a new release of the page UI. This update does not modify the study content, eligibility criteria, locations, or outcomes shown.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page’s displayed revision/version was updated from v3.5.2 to v3.5.3, reflecting a change to the site’s interface/versioning rather than the underlying clinical trial information.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check83 days agoChange Detected- Revision tag updated from v3.4.3 to v3.5.0, indicating a minor update. No changes to study details or eligibility information were observed.SummaryDifference0.1%

- Check97 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Avelumab in Chemo-resistant GTN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab in Chemo-resistant GTN Clinical Trial page.